Copyright
©The Author(s) 2024.
World J Gastroenterol. Jan 14, 2024; 30(2): 184-195
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.184
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.184
Variables | Clarithromycin | Levofloxacin | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age (yr) | ||||
< 50 | 1 | 1 | ||
≥ 50 | 2.379 (0.924-6.125) | 0.072 | 1.972 (0.888-4.379) | 0.095 |
Current smoking | ||||
No | 1 | 1 | ||
Yes | 1.151 (0.293-4.517) | 0.841 | 0.546 (0.192-1.557) | 0.258 |
Symptoms | ||||
No | 1 | 1 | ||
Yes | 2.782 (1.076-7.194) | 0.035 | 1.851 (0.823-4.166) | 0.137 |
Residence region | ||||
Urban | 1 | 1 | ||
Rural | 1.852 (0.489-7.010) | 0.364 | 5.152 (1.407-18.861) | 0.013 |
- Citation: Wang YM, Chen MY, Chen J, Zhang XH, Feng Y, Han YX, Li YL. Success of susceptibility-guided eradication of Helicobacter pylori in a region with high secondary clarithromycin and levofloxacin resistance rates. World J Gastroenterol 2024; 30(2): 184-195
- URL: https://www.wjgnet.com/1007-9327/full/v30/i2/184.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i2.184